224 related articles for article (PubMed ID: 21593806)
1. Downregulation of hepatic glucose-6-phosphatase-α in patients with hepatic steatosis.
Konopelska S; Kienitz T; Quinkler M
Obesity (Silver Spring); 2011 Dec; 19(12):2322-6. PubMed ID: 21593806
[TBL] [Abstract][Full Text] [Related]
2. Prevention of hepatocellular adenoma and correction of metabolic abnormalities in murine glycogen storage disease type Ia by gene therapy.
Lee YM; Jun HS; Pan CJ; Lin SR; Wilson LH; Mansfield BC; Chou JY
Hepatology; 2012 Nov; 56(5):1719-29. PubMed ID: 22422504
[TBL] [Abstract][Full Text] [Related]
3. New insights into the organisation and intracellular localisation of the two subunits of glucose-6-phosphatase.
Soty M; Chilloux J; Casteras S; Grichine A; Mithieux G; Gautier-Stein A
Biochimie; 2012 Mar; 94(3):695-703. PubMed ID: 21983240
[TBL] [Abstract][Full Text] [Related]
4. Hepatic 11beta-HSD1 mRNA expression in fatty liver and nonalcoholic steatohepatitis.
Konopelska S; Kienitz T; Hughes B; Pirlich M; Bauditz J; Lochs H; Strasburger CJ; Stewart PM; Quinkler M
Clin Endocrinol (Oxf); 2009 Apr; 70(4):554-60. PubMed ID: 18665910
[TBL] [Abstract][Full Text] [Related]
5. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C.
Miquilena-Colina ME; Lima-Cabello E; Sánchez-Campos S; García-Mediavilla MV; Fernández-Bermejo M; Lozano-Rodríguez T; Vargas-Castrillón J; Buqué X; Ochoa B; Aspichueta P; González-Gallego J; García-Monzón C
Gut; 2011 Oct; 60(10):1394-402. PubMed ID: 21270117
[TBL] [Abstract][Full Text] [Related]
6. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR
Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597
[TBL] [Abstract][Full Text] [Related]
8. Type I glycogen storage diseases: disorders of the glucose-6-phosphatase/glucose-6-phosphate transporter complexes.
Chou JY; Jun HS; Mansfield BC
J Inherit Metab Dis; 2015 May; 38(3):511-9. PubMed ID: 25288127
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between leptin gene of adipose tissues and nonalcoholic fatty liver disease].
Yang H; Li YY; Nie YQ; Hong T; Jiang QL; Sha WH
Zhonghua Gan Zang Bing Za Zhi; 2006 Nov; 14(11):828-31. PubMed ID: 17125610
[TBL] [Abstract][Full Text] [Related]
10. Visceral adipose tissue and inflammation correlate with elevated liver tests in a cohort of overweight and obese patients.
Verrijken A; Francque S; Mertens I; Talloen M; Peiffer F; Van Gaal L
Int J Obes (Lond); 2010 May; 34(5):899-907. PubMed ID: 20142825
[TBL] [Abstract][Full Text] [Related]
11. Molecular genetics of type 1 glycogen storage disease.
Janecke AR; Mayatepek E; Utermann G
Mol Genet Metab; 2001 Jun; 73(2):117-25. PubMed ID: 11386847
[TBL] [Abstract][Full Text] [Related]
12. Acute inhibition of glucose-6-phosphate translocator activity leads to increased de novo lipogenesis and development of hepatic steatosis without affecting VLDL production in rats.
Bandsma RH; Wiegman CH; Herling AW; Burger HJ; ter Harmsel A; Meijer AJ; Romijn JA; Reijngoud DJ; Kuipers F
Diabetes; 2001 Nov; 50(11):2591-7. PubMed ID: 11679439
[TBL] [Abstract][Full Text] [Related]
13. Post-Translational Regulation of the Glucose-6-Phosphatase Complex by Cyclic Adenosine Monophosphate Is a Crucial Determinant of Endogenous Glucose Production and Is Controlled by the Glucose-6-Phosphate Transporter.
Soty M; Chilloux J; Delalande F; Zitoun C; Bertile F; Mithieux G; Gautier-Stein A
J Proteome Res; 2016 Apr; 15(4):1342-9. PubMed ID: 26958868
[TBL] [Abstract][Full Text] [Related]
14. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
[TBL] [Abstract][Full Text] [Related]
15. Liver-directed gene therapy for murine glycogen storage disease type Ib.
Kwon JH; Lee YM; Cho JH; Kim GY; Anduaga J; Starost MF; Mansfield BC; Chou JY
Hum Mol Genet; 2017 Nov; 26(22):4395-4405. PubMed ID: 28973635
[TBL] [Abstract][Full Text] [Related]
16. A molecular link between the common phenotypes of type 1 glycogen storage disease and HNF1alpha-null mice.
Hiraiwa H; Pan CJ; Lin B; Akiyama TE; Gonzalez FJ; Chou JY
J Biol Chem; 2001 Mar; 276(11):7963-7. PubMed ID: 11121425
[TBL] [Abstract][Full Text] [Related]
17. Discriminant responses of the catalytic unit and glucose 6-phosphate transporter components of the hepatic glucose-6-phosphatase system in Ehrlich ascites-tumor-bearing mice.
Foster JD; Wiedemann JM; Pan CJ; Chou JY; Nordlie RC
Arch Biochem Biophys; 2001 Sep; 393(1):117-22. PubMed ID: 11516168
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of glucose-6-phosphatase expression contributes to fluoxetine-induced hepatic steatosis.
Lu S; Ma Z; Gu Y; Li P; Chen Y; Bai M; Zhou H; Yang X; Jiang H
J Appl Toxicol; 2021 Aug; 41(8):1232-1240. PubMed ID: 33179799
[TBL] [Abstract][Full Text] [Related]
19. Nutritional regulation of glucose-6-phosphatase gene expression in liver of the gilthead sea bream (Sparus aurata).
Caseras A; Metón I; Vives C; Egea M; Fernández F; Baanante IV
Br J Nutr; 2002 Dec; 88(6):607-14. PubMed ID: 12493082
[TBL] [Abstract][Full Text] [Related]
20. Specific reduction of G6PT may contribute to downregulation of hepatic 11β-HSD1 in diabetic mice.
Du H; Liu L; Wang Y; Nakagawa Y; Lyzlov A; Lutfy K; Friedman TC; Peng X; Liu Y
J Mol Endocrinol; 2013 Apr; 50(2):167-78. PubMed ID: 23267038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
